首页 > 最新文献

Head & Neck最新文献

英文 中文
Patterns of nodal involvement for clinically N0 salivary gland carcinoma: refining the role of elective neck irradiation. 临床涎腺癌淋巴结受累模式:细化择期颈部照射的作用。
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2014-01-13 DOI: 10.1002/hed.23467
Valerie H Lau, Rony Aouad, D Gregory Farwell, Paul J Donald, Allen M Chen

Background: The purpose of this study was to analyze the pattern of occult cervical lymph node metastasis among patients with clinically N0 salivary gland carcinoma.

Methods: One hundred nineteen patients underwent primary surgery and ipsilateral neck dissection for clinically N0 carcinomas of the major and minor salivary glands. Eighty patients (67%) had parotid tumors. Distribution of T classification was: T1 (18%), T2 (28%), T3 (23%), and T4 (32%).

Results: Twenty-five patients (21%) had pathological cervical disease. The incidence was highest among patients with adenocarcinoma (35%) and high-grade mucoepidermoid carcinoma (35%). The most common site of cervical lymph node metastasis was level II (71%), followed by level III (15%), and level IB (8%). On multivariate analysis, histological subtype was independently predictive of occult pathological lymph node metastasis (p < .001).

Conclusion: The likelihood of occult cervical lymph node metastasis for patients with salivary gland carcinoma is driven predominantly by histological subtype. Implications for elective neck irradiation are discussed.

背景:本研究的目的是分析临床N0型唾液腺癌患者隐匿性颈淋巴转移的模式。方法:对119例大、小唾液腺癌患者行原发性手术及同侧颈部清扫术。80例(67%)患者有腮腺肿瘤。T分型分布为:T1(18%)、T2(28%)、T3(23%)、T4(32%)。结果:病理宫颈病变25例(21%)。腺癌(35%)和高级别粘液表皮样癌(35%)的发病率最高。最常见的颈部淋巴结转移部位是II级(71%),其次是III级(15%)和IB级(8%)。在多变量分析中,组织学亚型是隐匿性病理性淋巴结转移的独立预测因子(p < 0.001)。结论:涎腺癌患者隐匿性颈淋巴转移的可能性主要由组织学亚型决定。讨论了择期颈部照射的意义。
{"title":"Patterns of nodal involvement for clinically N0 salivary gland carcinoma: refining the role of elective neck irradiation.","authors":"Valerie H Lau,&nbsp;Rony Aouad,&nbsp;D Gregory Farwell,&nbsp;Paul J Donald,&nbsp;Allen M Chen","doi":"10.1002/hed.23467","DOIUrl":"https://doi.org/10.1002/hed.23467","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to analyze the pattern of occult cervical lymph node metastasis among patients with clinically N0 salivary gland carcinoma.</p><p><strong>Methods: </strong>One hundred nineteen patients underwent primary surgery and ipsilateral neck dissection for clinically N0 carcinomas of the major and minor salivary glands. Eighty patients (67%) had parotid tumors. Distribution of T classification was: T1 (18%), T2 (28%), T3 (23%), and T4 (32%).</p><p><strong>Results: </strong>Twenty-five patients (21%) had pathological cervical disease. The incidence was highest among patients with adenocarcinoma (35%) and high-grade mucoepidermoid carcinoma (35%). The most common site of cervical lymph node metastasis was level II (71%), followed by level III (15%), and level IB (8%). On multivariate analysis, histological subtype was independently predictive of occult pathological lymph node metastasis (p < .001).</p><p><strong>Conclusion: </strong>The likelihood of occult cervical lymph node metastasis for patients with salivary gland carcinoma is driven predominantly by histological subtype. Implications for elective neck irradiation are discussed.</p>","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"1435-9"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23467","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31735165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 68
Stomal recurrence: salvage surgery and reconstruction utilizing microvascular free tissue transfer. 吻合口复发:利用微血管游离组织移植进行挽救性手术和重建。
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2013-12-18 DOI: 10.1002/hed.23468
Amy Pittman, Robert Lindau, Peter Andersen, Mark K Wax

Background: Stomal recurrence in patients after laryngectomy has a poor prognosis. Studies performed using sternal resection with pectoralis flap reconstruction report <25% 2-year survival. The purpose of this study was to ascertain whether the use of larger resection with free flap reconstruction improves survival.

Methods: Thirteen cases of stomal recurrence that underwent extended sternal resection and free flap reconstruction were identified and classified according to Sisson criteria. Postoperative morbidity, mortality, and survival were assessed.

Results: Median survival was 10 months in patients with Sisson types I and II, with 37.5% 1-year and 25% 2-year survival. Median survival was 6 months in patients with Sisson types III and IV, with 40% 1-year and 0% 2-year survival. There were 2 perioperative deaths and a major morbidity rate of 45%.

Conclusion: Salvage surgery using free flap reconstruction did not show improved survival rates compared with previously described techniques.

背景:喉切除术后造口复发预后较差。方法:对13例经扩大胸骨切除术和游离皮瓣重建的造口复发患者进行鉴定,并按Sisson标准进行分类。评估术后发病率、死亡率和生存率。结果:Sisson I型和II型患者的中位生存期为10个月,1年生存率为37.5%,2年生存率为25%。Sisson III型和IV型患者的中位生存期为6个月,1年生存率为40%,2年生存率为0%。围手术期死亡2例,主要发病率45%。结论:与先前描述的技术相比,使用游离皮瓣重建的挽救手术并没有显示出更高的存活率。
{"title":"Stomal recurrence: salvage surgery and reconstruction utilizing microvascular free tissue transfer.","authors":"Amy Pittman,&nbsp;Robert Lindau,&nbsp;Peter Andersen,&nbsp;Mark K Wax","doi":"10.1002/hed.23468","DOIUrl":"https://doi.org/10.1002/hed.23468","url":null,"abstract":"<p><strong>Background: </strong>Stomal recurrence in patients after laryngectomy has a poor prognosis. Studies performed using sternal resection with pectoralis flap reconstruction report <25% 2-year survival. The purpose of this study was to ascertain whether the use of larger resection with free flap reconstruction improves survival.</p><p><strong>Methods: </strong>Thirteen cases of stomal recurrence that underwent extended sternal resection and free flap reconstruction were identified and classified according to Sisson criteria. Postoperative morbidity, mortality, and survival were assessed.</p><p><strong>Results: </strong>Median survival was 10 months in patients with Sisson types I and II, with 37.5% 1-year and 25% 2-year survival. Median survival was 6 months in patients with Sisson types III and IV, with 40% 1-year and 0% 2-year survival. There were 2 perioperative deaths and a major morbidity rate of 45%.</p><p><strong>Conclusion: </strong>Salvage surgery using free flap reconstruction did not show improved survival rates compared with previously described techniques.</p>","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"1431-4"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23468","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31735299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Facelift approach for mandibular resection and reconstruction. 下颌骨切除重建的拉皮入路。
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2013-12-18 DOI: 10.1002/hed.23484
Bernardo Bianchi, Andrea Ferri, Silvano Ferrari, Chiara Copelli, Enrico Sesenna
Mandibular resection is the mainstay in the treatment of several pathologies involving the jaw. When benign lesions are approached, a limited exposure and less invasive access considering the cosmetic outcome is desirable to reduce morbidity and increase patient's quality of life after surgery. The facelift approach is widely used for rhytidectomy, parotidectomy, and facial animation procedures, whereas its use for mandibular resection and reconstruction is not described yet.
背景:下颌骨切除术是治疗几种颌骨病变的主要方法。当接近良性病变时,考虑到美容效果,有限的暴露和较少的侵入性接触是减少发病率和提高患者术后生活质量的理想选择。拉皮入路广泛用于除皱、腮腺切除和面部动画手术,而其在下颌切除和重建中的应用尚未被描述。方法:回顾性分析6例采用游离皮瓣或骨移植行下颌骨切除术重建的患者的功能和外观。结果:未发生闭塞或面神经损伤;4例患者开口正常,2例部分受限。3例患者美容效果评价为优,3例评价为良。结论:拉皮入路是切除和重建下颌支、角和后体良性病变的有效选择。
{"title":"Facelift approach for mandibular resection and reconstruction.","authors":"Bernardo Bianchi,&nbsp;Andrea Ferri,&nbsp;Silvano Ferrari,&nbsp;Chiara Copelli,&nbsp;Enrico Sesenna","doi":"10.1002/hed.23484","DOIUrl":"https://doi.org/10.1002/hed.23484","url":null,"abstract":"Mandibular resection is the mainstay in the treatment of several pathologies involving the jaw. When benign lesions are approached, a limited exposure and less invasive access considering the cosmetic outcome is desirable to reduce morbidity and increase patient's quality of life after surgery. The facelift approach is widely used for rhytidectomy, parotidectomy, and facial animation procedures, whereas its use for mandibular resection and reconstruction is not described yet.","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"1497-502"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23484","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31700320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Reply to letter to the editor regarding investigation of laryngeal basaloid squamous cell carcinoma prognosis. 关于喉部基底样鳞状细胞癌预后调查的复函编辑。
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2014-08-28 DOI: 10.1002/hed.23769
Valerie Fritsch, Eric Lentsch
To the Editor: I read with great interest the recent article by Fritsch and Lentsch, who investigated laryngeal basaloid squamous cell carcinoma (BSCC) prognosis using the populationbased cancer registries of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Although the study by Fritsch and Lentsch is inevitably characterized by a potential bias relating to the fact that the cases of BSCC were diagnosed and treated by different teams and in different ways, the numerosity of the cases considered is remarkable. These studies are important, particularly those comparing the prognosis for head and neck BSCC as opposed to conventional squamous cell carcinoma (SCC) in site-matched and stage-matched settings, because numerous—but not all—investigators currently believe that head and neck BSCC is a significantly more aggressive lesion and carries a worse prognosis than the more commonly encountered SCC. Confirmation of the greater aggressiveness of head and neck BSCC visa-vis conventional SCC could rationally justify a more aggressive approach to their locoregional treatment and possibly the use of adjuvant chemotherapy in head and neck BSCC. However, because the mistakes made (and reiterated) in citations eventually have a significant impact on the international medical literature, I have to point out that, in their reference number 22, Fritsch and Lentsch misquote the content of a study conducted by our group in this field. In the investigation concerned, the 9 BSCCs considered did not all arise in the larynx (but 5 in the larynx, 3 in the tongue, and 1 in the tonsil), whereas another study by our group analyzed the prognostic role of the apoptosis inhibitor protein survivin in 9 consecutive cases of laryngeal BSCC, and, in this latter series, the diseasespecific survival (DSS) was 55.6%. In speaking about the prognosis for BSCC of the head and neck, it is extremely important to be accurate about the site involved by the primary lesion. In fact, a more recent study by Fritsch and Lentsch concluded that the DSS of patients treated for laryngeal BSCC was significantly lower than for patients with conventional SCC on multivariate analysis, but patients with oropharyngeal BSCC had a higher DSS than those with oropharyngeal conventional SCC (reported data source: Surveillance, Epidemiology, and End Results Program of the National Cancer Institute, September 2005; size of the populations considered: 1083 head and neck BSCCs, 66,929 conventional SCC).
{"title":"Reply to letter to the editor regarding investigation of laryngeal basaloid squamous cell carcinoma prognosis.","authors":"Valerie Fritsch,&nbsp;Eric Lentsch","doi":"10.1002/hed.23769","DOIUrl":"https://doi.org/10.1002/hed.23769","url":null,"abstract":"To the Editor: I read with great interest the recent article by Fritsch and Lentsch, who investigated laryngeal basaloid squamous cell carcinoma (BSCC) prognosis using the populationbased cancer registries of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Although the study by Fritsch and Lentsch is inevitably characterized by a potential bias relating to the fact that the cases of BSCC were diagnosed and treated by different teams and in different ways, the numerosity of the cases considered is remarkable. These studies are important, particularly those comparing the prognosis for head and neck BSCC as opposed to conventional squamous cell carcinoma (SCC) in site-matched and stage-matched settings, because numerous—but not all—investigators currently believe that head and neck BSCC is a significantly more aggressive lesion and carries a worse prognosis than the more commonly encountered SCC. Confirmation of the greater aggressiveness of head and neck BSCC visa-vis conventional SCC could rationally justify a more aggressive approach to their locoregional treatment and possibly the use of adjuvant chemotherapy in head and neck BSCC. However, because the mistakes made (and reiterated) in citations eventually have a significant impact on the international medical literature, I have to point out that, in their reference number 22, Fritsch and Lentsch misquote the content of a study conducted by our group in this field. In the investigation concerned, the 9 BSCCs considered did not all arise in the larynx (but 5 in the larynx, 3 in the tongue, and 1 in the tonsil), whereas another study by our group analyzed the prognostic role of the apoptosis inhibitor protein survivin in 9 consecutive cases of laryngeal BSCC, and, in this latter series, the diseasespecific survival (DSS) was 55.6%. In speaking about the prognosis for BSCC of the head and neck, it is extremely important to be accurate about the site involved by the primary lesion. In fact, a more recent study by Fritsch and Lentsch concluded that the DSS of patients treated for laryngeal BSCC was significantly lower than for patients with conventional SCC on multivariate analysis, but patients with oropharyngeal BSCC had a higher DSS than those with oropharyngeal conventional SCC (reported data source: Surveillance, Epidemiology, and End Results Program of the National Cancer Institute, September 2005; size of the populations considered: 1083 head and neck BSCCs, 66,929 conventional SCC).","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"1527-8"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23769","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32349657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strangling technique to treat large cervicofacial venous malformations: a preliminary report. 勒死术治疗颈面大静脉畸形的初步报告。
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2014-04-03 DOI: 10.1002/hed.23585
Giacomo Colletti, Valeria Colombo, Raul Mattassi, Alice Frigerio

Background: Surgical removal of large cervicofacial venous malformations might be hampered by massive intraoperative bleeding. Moreover, these lesions often insinuate within normal surrounding tissue, making complete resection impossible without causing significant morbidity.

Methods: Two patients affected by facial venous malformations nonresponsive to sclerotherapy underwent surgery. Bleeding and critical branching of the facial nerve within the lesion prevented the surgeons from proceeding with the removal. The unresectable malformation was decompressed by means of a number of nonresorbable stitches from the surface of the lesion to the periosteum, tailoring a permanent pressure dressing.

Results: Outcomes at 12-month follow-up were stable, with good cosmetic results and satisfaction reported by both patients. No long-term side effects related to the procedure were observed.

Conclusion: Decompression of large venous malformations by means of a strangling technique might represent a safe and effective procedure for those cases where a removal cannot be accomplished.

背景:手术切除大面积颈面静脉畸形可能会因术中大量出血而受阻。此外,这些病变经常在正常的周围组织中浸润,使得完全切除不可能不引起显著的发病率。方法:对2例硬化治疗无效的面部静脉畸形患者进行手术治疗。病变内的出血和严重的面神经分支使外科医生无法继续切除。不可切除的畸形通过从病变表面到骨膜的一些不可吸收的缝线进行减压,定制永久性压力敷料。结果:随访12个月,结果稳定,两例患者美容效果良好,满意。没有观察到与手术相关的长期副作用。结论:对于那些不能完成切除的病例,采用勒死技术对大静脉畸形进行减压可能是一种安全有效的方法。
{"title":"Strangling technique to treat large cervicofacial venous malformations: a preliminary report.","authors":"Giacomo Colletti,&nbsp;Valeria Colombo,&nbsp;Raul Mattassi,&nbsp;Alice Frigerio","doi":"10.1002/hed.23585","DOIUrl":"https://doi.org/10.1002/hed.23585","url":null,"abstract":"<p><strong>Background: </strong>Surgical removal of large cervicofacial venous malformations might be hampered by massive intraoperative bleeding. Moreover, these lesions often insinuate within normal surrounding tissue, making complete resection impossible without causing significant morbidity.</p><p><strong>Methods: </strong>Two patients affected by facial venous malformations nonresponsive to sclerotherapy underwent surgery. Bleeding and critical branching of the facial nerve within the lesion prevented the surgeons from proceeding with the removal. The unresectable malformation was decompressed by means of a number of nonresorbable stitches from the surface of the lesion to the periosteum, tailoring a permanent pressure dressing.</p><p><strong>Results: </strong>Outcomes at 12-month follow-up were stable, with good cosmetic results and satisfaction reported by both patients. No long-term side effects related to the procedure were observed.</p><p><strong>Conclusion: </strong>Decompression of large venous malformations by means of a strangling technique might represent a safe and effective procedure for those cases where a removal cannot be accomplished.</p>","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"E94-8"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23585","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31986997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis. 表皮生长因子受体在鼻咽癌预后中的作用:荟萃分析。
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2013-12-18 DOI: 10.1002/hed.23481
Wei Sun, Guoxian Long, Junfeng Wang, Qi Mei, Dongbo Liu, Guoqing Hu

Background: Various studies have assessed the prognostic value of epidermal growth factor receptor (EGFR) overexpression in nasopharyngeal carcinoma (NPC), but their results remain controversial.

Methods: Studies published up to January 2013 were collected. A total of 16 studies involving 1179 patients were reviewed. A meta-analysis was performed to clarify the prognostic role of EGFR in patients with NPC. The combined hazard ratio (HR) and 95% confidence interval (CI) were estimated using fixed-effects or random-effects models.

Results: EGFR overexpression had significantly poor effect on overall survival (OS; HR, 1.86; 95% CI, 1.25-2.77), disease-free survival (DFS; HR, 2.25; 95% CI, 1.66-3.04) and locoregional control (HR, 2.93; 95% CI, 1.71-5.02). However, the association between EGFR overexpression and distant metastasis-free survival was not statistically significant (HR, 1.39; 95% CI, 0.72-2.67).

Conclusion: EGFR overexpression can be a prognostic factor for patients with NPC.

背景:各种研究评估了表皮生长因子受体(EGFR)过表达在鼻咽癌(NPC)中的预后价值,但其结果仍存在争议。方法:收集截至2013年1月已发表的研究。共纳入16项研究,涉及1179例患者。进行了一项荟萃分析,以阐明EGFR在鼻咽癌患者中的预后作用。使用固定效应或随机效应模型估计联合风险比(HR)和95%置信区间(CI)。结果:EGFR过表达对总生存期(OS;人力资源,1.86;95% CI, 1.25-2.77),无病生存期(DFS;人力资源,2.25;95% CI, 1.66-3.04)和局部区域对照(HR, 2.93;95% ci, 1.71-5.02)。然而,EGFR过表达与远端无转移生存之间的相关性无统计学意义(HR, 1.39;95% ci, 0.72-2.67)。结论:EGFR过表达可能是鼻咽癌患者预后的一个影响因素。
{"title":"Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis.","authors":"Wei Sun,&nbsp;Guoxian Long,&nbsp;Junfeng Wang,&nbsp;Qi Mei,&nbsp;Dongbo Liu,&nbsp;Guoqing Hu","doi":"10.1002/hed.23481","DOIUrl":"https://doi.org/10.1002/hed.23481","url":null,"abstract":"<p><strong>Background: </strong>Various studies have assessed the prognostic value of epidermal growth factor receptor (EGFR) overexpression in nasopharyngeal carcinoma (NPC), but their results remain controversial.</p><p><strong>Methods: </strong>Studies published up to January 2013 were collected. A total of 16 studies involving 1179 patients were reviewed. A meta-analysis was performed to clarify the prognostic role of EGFR in patients with NPC. The combined hazard ratio (HR) and 95% confidence interval (CI) were estimated using fixed-effects or random-effects models.</p><p><strong>Results: </strong>EGFR overexpression had significantly poor effect on overall survival (OS; HR, 1.86; 95% CI, 1.25-2.77), disease-free survival (DFS; HR, 2.25; 95% CI, 1.66-3.04) and locoregional control (HR, 2.93; 95% CI, 1.71-5.02). However, the association between EGFR overexpression and distant metastasis-free survival was not statistically significant (HR, 1.39; 95% CI, 0.72-2.67).</p><p><strong>Conclusion: </strong>EGFR overexpression can be a prognostic factor for patients with NPC.</p>","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"1508-16"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23481","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31700006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 29
Experience of palliative care for patients with head and neck cancer through the eyes of next of kin: impact of an Expert Center. 通过近亲的眼睛对头颈癌患者进行姑息治疗的经验:专家中心的影响。
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2013-12-18 DOI: 10.1002/hed.23489
Marinella P J Offerman, Jean F A Pruyn, Maarten F de Boer, Quirine C P Ledeboer, Jan J van Busschbach, Robert J Baatenburg de Jong, Lilly-Ann van der Velden

Background: Literature is scarce on the palliative care experiences of patients with head and neck cancer. We report our experience in this patient population after the establishment of our Expert Center.

Methods: We administered a questionnaire to 40 surviving relatives of patients with head and neck cancer after the establishment of our Expert Center and compared the results to a similar group of patients with head and neck cancer before the establishment of our Expert Center.

Results: Since the establishment of our Expert Center, we found: an improved evaluation of the psychosocial support offered; better contact between head and neck surgeons, the patients, and families; and improvement in the quantity of information in the palliative phase. Some relatives, however, reported that patients received treatment against their wishes and life was not made as comfortable as possible.

Conclusion: Important aspects of palliative care, such as psychosocial support and contact between patient and surgeon, have been improved since the establishment of our Expert Center.

背景:关于头颈癌患者姑息治疗经验的文献很少。我们在专家中心成立后报告我们在这一患者群体中的经验。方法:对40例头颈癌患者在专家中心成立后幸存的亲属进行问卷调查,并与专家中心成立前的同类头颈癌患者进行比较。结果:自专家中心成立以来,我们发现:心理社会支持的评估有所改善;头颈外科医生、患者和家属之间更好的联系;以及缓和期信息量的提高。然而,一些亲属报告说,病人接受了违背他们意愿的治疗,生活没有尽可能舒适。结论:自专家中心成立以来,姑息治疗的重要方面,如心理社会支持和患者与外科医生的接触得到了改善。
{"title":"Experience of palliative care for patients with head and neck cancer through the eyes of next of kin: impact of an Expert Center.","authors":"Marinella P J Offerman,&nbsp;Jean F A Pruyn,&nbsp;Maarten F de Boer,&nbsp;Quirine C P Ledeboer,&nbsp;Jan J van Busschbach,&nbsp;Robert J Baatenburg de Jong,&nbsp;Lilly-Ann van der Velden","doi":"10.1002/hed.23489","DOIUrl":"https://doi.org/10.1002/hed.23489","url":null,"abstract":"<p><strong>Background: </strong>Literature is scarce on the palliative care experiences of patients with head and neck cancer. We report our experience in this patient population after the establishment of our Expert Center.</p><p><strong>Methods: </strong>We administered a questionnaire to 40 surviving relatives of patients with head and neck cancer after the establishment of our Expert Center and compared the results to a similar group of patients with head and neck cancer before the establishment of our Expert Center.</p><p><strong>Results: </strong>Since the establishment of our Expert Center, we found: an improved evaluation of the psychosocial support offered; better contact between head and neck surgeons, the patients, and families; and improvement in the quantity of information in the palliative phase. Some relatives, however, reported that patients received treatment against their wishes and life was not made as comfortable as possible.</p><p><strong>Conclusion: </strong>Important aspects of palliative care, such as psychosocial support and contact between patient and surgeon, have been improved since the establishment of our Expert Center.</p>","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"1459-66"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23489","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31701115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Prospective study of 583 neck dissections in oral cancers: implications for clinical practice. 583例口腔癌颈部解剖的前瞻性研究:对临床实践的启示。
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2014-01-13 DOI: 10.1002/hed.23494
Gouri H Pantvaidya, Pooja Pal, Abhishek D Vaidya, Prathamesh S Pai, Anil K D'Cruz

Background: Determining the level of nodal metastases may help decrease the extent of neck dissections and reduce morbidity.

Methods: A prospective study of neck dissections in patients with oral cancer was conducted. Each nodal level was delineated, sent for histopathology, and reported level-wise. Incidence of overall and isolated metastatic nodes at different levels was calculated. Logistic regression was used to find factors predicting metastases to levels IIB and V.

Results: Five hundred eighty-three neck dissections were prospectively evaluated. A total of 95.7% metastases occurred at levels I to IV. Overall incidence of metastases to levels IIB and V was 3.8% and 3.3%, respectively. Multivariate analysis revealed IIA positivity as an independent predictive factor for metastases to both IIB and V.

Conclusion: This study of lymph node mapping in patients with oral cancer showed a predictable pattern of lymph node metastasis according to primary site. Selective neck dissection (levels I-IV) in patients with oral cancers may be adequate. Determining status of level IIA is important to guide dissection of levels IIB and V.

背景:确定淋巴结转移水平可能有助于减少颈部清扫的范围和降低发病率。方法:对口腔癌患者颈部清扫术进行前瞻性研究。每个淋巴结水平被划定,送去组织病理学检查,并逐级报告。计算不同水平的总体和孤立转移淋巴结的发生率。使用Logistic回归寻找预测转移到IIB和v水平的因素。结果:583例颈部解剖进行了前瞻性评估。共有95.7%的转移发生在I至IV级。转移到IIB和V级的总发生率分别为3.8%和3.3%。多因素分析显示,IIA阳性是IIB和v转移的独立预测因素。结论:口腔癌患者的淋巴结作图研究显示,根据原发部位,可以预测淋巴结转移模式。口腔癌患者的选择性颈部清扫(I-IV级)可能是足够的。确定IIA节段的状态对指导IIB和V节段的解剖具有重要意义。
{"title":"Prospective study of 583 neck dissections in oral cancers: implications for clinical practice.","authors":"Gouri H Pantvaidya,&nbsp;Pooja Pal,&nbsp;Abhishek D Vaidya,&nbsp;Prathamesh S Pai,&nbsp;Anil K D'Cruz","doi":"10.1002/hed.23494","DOIUrl":"https://doi.org/10.1002/hed.23494","url":null,"abstract":"<p><strong>Background: </strong>Determining the level of nodal metastases may help decrease the extent of neck dissections and reduce morbidity.</p><p><strong>Methods: </strong>A prospective study of neck dissections in patients with oral cancer was conducted. Each nodal level was delineated, sent for histopathology, and reported level-wise. Incidence of overall and isolated metastatic nodes at different levels was calculated. Logistic regression was used to find factors predicting metastases to levels IIB and V.</p><p><strong>Results: </strong>Five hundred eighty-three neck dissections were prospectively evaluated. A total of 95.7% metastases occurred at levels I to IV. Overall incidence of metastases to levels IIB and V was 3.8% and 3.3%, respectively. Multivariate analysis revealed IIA positivity as an independent predictive factor for metastases to both IIB and V.</p><p><strong>Conclusion: </strong>This study of lymph node mapping in patients with oral cancer showed a predictable pattern of lymph node metastasis according to primary site. Selective neck dissection (levels I-IV) in patients with oral cancers may be adequate. Determining status of level IIA is important to guide dissection of levels IIB and V.</p>","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"1503-7"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23494","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31699432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 54
Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity. 奈达铂联合紫杉醇或氟尿嘧啶同步放化疗治疗局部进展期鼻咽癌:生存和毒性
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2014-02-01 DOI: 10.1002/hed.23487
Jianhua Xu, Xia He, Kong Cheng, Wenjie Guo, Xiuhua Bian, Xuesong Jiang, Lanfang Zhang, Shengfu Huang

Background: The purpose of this study was to review the survival and toxicity in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiation therapy (IMRT) and concurrent nedaplatin plus paclitaxel or fluorouracil (NP or NF).

Methods: A total of 155 patients with locoregionally advanced NPC seen at our institution between January 2008 and December 2010 were retrospectively reviewed. Seventy-nine cases (51%) were treated with IMRT and concurrent NP chemotherapy, and 76 cases (49%) were treated with IMRT and concurrent NF regimen. Survival and toxicity were reported.

Results: The 3-year locoregional relapse-free survival, distant metastasis-free survival, progression-free survival (PFS), and overall survival (OS) rates were 90.3% and 87.8%, 79.7% and 81.1%, 77.3% and 71.1%, and 81.6% and 83.7% for the NF and NP group, respectively. The results were comparable to that of the cisplatin-based regimens. Acute and late toxicities were acceptable.

Conclusion: IMRT with concurrent nedaplatin-based chemotherapy achieved comparable survival with acceptable toxicity to those of the cisplatin-based regimens in the treatment of locoregionally advanced NPC.

背景:本研究的目的是回顾调强放疗(IMRT)和奈达铂联合紫杉醇或氟尿嘧啶(NP或NF)治疗局部晚期鼻咽癌(NPC)患者的生存和毒性。方法:回顾性分析2008年1月至2010年12月我院收治的155例局部晚期鼻咽癌患者。IMRT联合NP化疗79例(51%),IMRT联合NF化疗76例(49%)。报告了存活率和毒性。结果:NF组和NP组3年局部无复发生存率、远处无转移生存率、无进展生存率(PFS)和总生存率(OS)分别为90.3%和87.8%、79.7%和81.1%、77.3%和71.1%、81.6%和83.7%。结果与以顺铂为基础的方案相当。急性和晚期毒性是可以接受的。结论:与以顺铂为基础的方案相比,IMRT联合以奈达铂为基础的化疗在治疗局部区域晚期鼻咽癌方面取得了相当的生存期和可接受的毒性。
{"title":"Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity.","authors":"Jianhua Xu,&nbsp;Xia He,&nbsp;Kong Cheng,&nbsp;Wenjie Guo,&nbsp;Xiuhua Bian,&nbsp;Xuesong Jiang,&nbsp;Lanfang Zhang,&nbsp;Shengfu Huang","doi":"10.1002/hed.23487","DOIUrl":"https://doi.org/10.1002/hed.23487","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to review the survival and toxicity in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiation therapy (IMRT) and concurrent nedaplatin plus paclitaxel or fluorouracil (NP or NF).</p><p><strong>Methods: </strong>A total of 155 patients with locoregionally advanced NPC seen at our institution between January 2008 and December 2010 were retrospectively reviewed. Seventy-nine cases (51%) were treated with IMRT and concurrent NP chemotherapy, and 76 cases (49%) were treated with IMRT and concurrent NF regimen. Survival and toxicity were reported.</p><p><strong>Results: </strong>The 3-year locoregional relapse-free survival, distant metastasis-free survival, progression-free survival (PFS), and overall survival (OS) rates were 90.3% and 87.8%, 79.7% and 81.1%, 77.3% and 71.1%, and 81.6% and 83.7% for the NF and NP group, respectively. The results were comparable to that of the cisplatin-based regimens. Acute and late toxicities were acceptable.</p><p><strong>Conclusion: </strong>IMRT with concurrent nedaplatin-based chemotherapy achieved comparable survival with acceptable toxicity to those of the cisplatin-based regimens in the treatment of locoregionally advanced NPC.</p>","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"1474-80"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23487","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31700035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival. TNM分期与一种新的临床病理模型在预测口腔舌鳞癌生存中的比较。
IF 2.9 Pub Date : 2014-10-01 Epub Date: 2014-01-13 DOI: 10.1002/hed.23486
Oluwafunmilola T Okuyemi, Jay F Piccirillo, Edward Spitznagel

Background: The purpose of this study was to investigate the prognostic impact of comorbidity and of demographic and pathological factors on oral tongue squamous cell carcinoma (SCC) survival, and to compare the prognostic performance of a new clinicopathological model against the routinely used TNM staging.

Methods: We conducted a retrospective study of demographic, clinical, and pathological information of 166 patients with oral tongue SCC. Cox regression was used for multivariate analysis, model building, and model discriminatory analysis.

Results: Comorbidity had the most significant impact on overall survival (OS; log-rank test, chi-square  =  36.34; p  <  .0001). Comorbidity, tumor dimension >2 cm, and presence of extracapsular spread (ECS) or vascular invasion were independent predictors of survival. A clinicopathological model based on these 4 variables (chi-square  =  60.23; p  <  .0001) was better (c-statistic  =  0.736) at predicting survival compared to pathological TNM staging (c-statistic = 0.645).

Conclusion: Comorbidity combined with tumor dimension, ECS, and vascular invasion provide a better prediction of oral tongue SCC survival than TNM staging alone.

背景:本研究的目的是探讨合并症、人口学和病理因素对口腔舌鳞癌(SCC)生存的影响,并比较一种新的临床病理模型与常规使用的TNM分期的预后表现。方法:对166例口腔舌鳞癌患者的人口学、临床及病理资料进行回顾性分析。采用Cox回归进行多变量分析、模型建立和模型判别分析。结果:共病对总生存期(OS;Log-rank检验,卡方= 36.34;P < 0.0001)。合并症、肿瘤尺寸> 2cm、存在囊外扩散(ECS)或血管侵犯是生存的独立预测因素。基于这4个变量的临床病理模型(卡方= 60.23;p < 0.0001)在预测生存方面优于病理TNM分期(c-statistic = 0.736) (c-statistic = 0.645)。结论:与单纯的TNM分期相比,合并症与肿瘤尺寸、ECS和血管侵犯的结合能更好地预测口腔舌鳞癌的生存。
{"title":"TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival.","authors":"Oluwafunmilola T Okuyemi,&nbsp;Jay F Piccirillo,&nbsp;Edward Spitznagel","doi":"10.1002/hed.23486","DOIUrl":"https://doi.org/10.1002/hed.23486","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to investigate the prognostic impact of comorbidity and of demographic and pathological factors on oral tongue squamous cell carcinoma (SCC) survival, and to compare the prognostic performance of a new clinicopathological model against the routinely used TNM staging.</p><p><strong>Methods: </strong>We conducted a retrospective study of demographic, clinical, and pathological information of 166 patients with oral tongue SCC. Cox regression was used for multivariate analysis, model building, and model discriminatory analysis.</p><p><strong>Results: </strong>Comorbidity had the most significant impact on overall survival (OS; log-rank test, chi-square  =  36.34; p  <  .0001). Comorbidity, tumor dimension >2 cm, and presence of extracapsular spread (ECS) or vascular invasion were independent predictors of survival. A clinicopathological model based on these 4 variables (chi-square  =  60.23; p  <  .0001) was better (c-statistic  =  0.736) at predicting survival compared to pathological TNM staging (c-statistic = 0.645).</p><p><strong>Conclusion: </strong>Comorbidity combined with tumor dimension, ECS, and vascular invasion provide a better prediction of oral tongue SCC survival than TNM staging alone.</p>","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"1481-9"},"PeriodicalIF":2.9,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.23486","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31701255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 30
期刊
Head & Neck
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1